Cargando…
Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson’s Disease by Suppressing the JNK/AP-1 Pathway
Compound Dihuang Granule (CDG) is widely used in traditional Chinese medicine (TCM) for the treatment of Parkinson’s disease (PD). It has been shown to alleviate PD symptoms. However, the molecular mechanisms of its action have not been established. To establish the molecular mechanisms of CDG again...
Autores principales: | Wang, Li, Yang, Yu-fang, Chen, Long, He, Zhu-qing, Bi, Dian-yong, Zhang, Lei, Xu, Yan-wu, He, Jian-cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060647/ https://www.ncbi.nlm.nih.gov/pubmed/33897417 http://dx.doi.org/10.3389/fphar.2021.621359 |
Ejemplares similares
-
Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson’s disease
por: Ruan, Sisi, et al.
Publicado: (2023) -
Platycodin D induces apoptosis through JNK1/AP-1/PUMA pathway in non-small cell lung cancer cells: A new mechanism for an old compound
por: Chen, Shuntai, et al.
Publicado: (2022) -
miR-26 Induces Apoptosis and Inhibits Autophagy in Non-small Cell Lung Cancer Cells by Suppressing TGF-β1-JNK Signaling Pathway
por: He, Yi, et al.
Publicado: (2019) -
Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015) -
Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson’s Disease Mice via Inhibiting TLR4/NF-κB Signaling
por: He, Zhu-qing, et al.
Publicado: (2023)